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Purpose: Carotid endarterectomy (CEA) after acute stroke is generally delayed 6 to 8 weeks because of fear of stroke
progression. This delay can result in an interval stroke rate of 9% to 15%. We analyzed our results with CEA performed
within 1 to 4 weeks of stroke.
Methods: Records for all patients undergoing CEA after stroke between 1980 and 2001 were analyzed. Perioperative
evaluation included carotid duplex scanning or angiography, and head computed tomography or magnetic resonance
imaging. All patients with nonworsening neurologic status, additional brain territory at risk for recurrent stroke, and
severe ipsilateral carotid stenosis underwent CEA. Patients were grouped according to time of CEA after stroke: group
1, first week; group 2, second week; group 3, third week; group 4, fourth week. Statistical analysis was performed with
the 2 test, logistic regression, and analysis of variance.
Results: Two hundred twenty-eight patients underwent CEA within 1 to 4 weeks of stroke. Perioperative permanent
neurologic deficits occurred in 2.8% of patients in group 1 (72 procedures), 3.4% of patients in group 2 (59 procedures),
3.4% of patients in group 3 (29 procedures), and 2.6% of patients in group 4 (78 procedures). There was no relationship
between location or size of preoperative infarct and time of surgery. Only preoperative infarct size correlated with
probability of neurologic deficit after CEA (P < .05).
Conclusion: Incidence of postoperative stroke exacerbation is similar at all intervals. The results are within acceptable
limits for treatment of symptomatic carotid stenosis. CEA may be performed within 1 month of stroke with similar results
at all intervals during this period. (J Vasc Surg 2004;39:148-54.)
Although the rationale for treatment of carotid stenosis
and minor completed stroke is supported by data from
well-controlled prospective trials, the time of carotid end-
arterectomy (CEA) after acute stroke remains controver-
sial.1,2 In previous reports, a delay of 6 to 8 weeks between
onset of stroke and surgery was recommended to reduce
the risk for conversion of a bland infarct to a hemorrhagic
infarct.3,4 Recommendations to delay carotid surgery 6
weeks after stroke were reinforced by the conclusions of the
Joint Study of Extracranial Arterial Occlusion3 and sup-
ported by a retrospective study by Giordano et al4 that
demonstrated increased rate of postoperative stroke exac-
erbation in patients undergoing CEA within 5 weeks of
stroke as compared with CEA at later intervals. The dismal
outcome in earlier studies was often a result of poor patient
selection, inasmuch as these patients often had a profound
neurologic deficit in the setting of acute carotid artery
occlusion.5,6
In several studies the interval between stroke and treat-
ment was shortened to less than 4 weeks.7-10 In addition,
several studies have shown the efficacy of carotid surgery in
patients with recent stroke and internal carotid artery oc-
clusion.11,12 Many of these studies recommend a waiting
period in patients with areas of infarction on preoperative
brain imaging studies.
We reviewed the results of CEA performed within 1
month of acute stroke to identify factors and surgical prac-
tices that might have a positive effect on patient outcome.
METHODS
Records for all patients undergoing CEA after ipsilat-
eral acute stroke between 1980 and 2001 were reviewed.
Data had been prospectively collected in a computerized
database. Analysis of data for patients who underwent
surgery within 1 month of stroke was performed. Patient
demographic data, including history of diabetes mellitus,
cigarette smoking, hypertension, and coronary artery dis-
ease, were identified. When available, preoperative brain
computed tomography (CT) scans and magnetic resonance
(MR) images were reviewed, and infarct size and lesion
location were tabulated according to criteria of the North
American Symptomatic Carotid Endarterectomy Trial
(NASCET). Preoperative assessment included clinical ex-
amination, brain imaging studies, and carotid artery duplex
scanning, supplemented with biplanar contrast-enhanced
or MR angiography of extracranial carotid and vertebral
arteries with intracerebral arterial runoff. In all patients the
neurologic deficit at clinical examination had been present
for longer than 24 hours or an infarct referable for clinical
examination was present on preoperative brain imaging
studies. Patients with carotid arteries ipsilateral to the side
of clinical infarct with stenosis greater than 50% underwent
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CEA. In general, patients underwent CEA once neurologic
symptoms had reached plateau. The interval from time of
stroke to performance of CEA was dictated by the time to
referral by the neurologist or physician to the Institute for
Vascular Health and Disease at Albany Medical College. In
a small subset of patients, operation was performed for
stroke in evolution, in which case the interval between
stroke and surgery was less than 24 hours. In all patients in
this series there was residual cerebral territory at risk for
further stroke; that is, there were no complete middle
cerebral artery distribution strokes. Patients with profound
neurologic deficit, as manifested by dense hemiparesis sug-
gestive of large area middle cerebral artery infarction with
obtundation, did not undergo surgical treatment.
CEA was performed with either general anesthesia or
deep and superficial cervical plexus blockade, depending on
surgeon preference. CEA technique involved either stan-
dard longitudinal or eversion endarterectomy, as de-
scribed.13 Shunts were placed routinely in patients under
general anesthesia and selectively because of neurologic
deterioration in patients under cervical blockade anesthesia.
Neurologic deficits occurring after CEA were classified
as transient if there was complete clinical resolution within
24 hours and no infarct on repeat brain CT scans or MR
images. Permanent deficits included exacerbation of previ-
ous clinical deficit lasting longer than 24 hours, with or
without demonstrable extension of the preoperative infarct
or development of a new ipsilateral cerebral infarct. Post-
operative neurologic status was evaluated by the vascular
surgical service in all patients, with supplemental evaluation
by a neurologist in most patients. In the last 2 years of the
study all patients were evaluated preoperatively and post-
operatively by a consulting neurologist in addition to the
vascular surgical service. Patients were seen postoperatively
within 1 month after hospital discharge, at 3 months, and at
6-month intervals thereafter.
Patients were separated into four groups according to
interval between stroke onset and performance of CEA:
group 1, less than 1 week; group 2, 1 to 2 weeks; group 3,
2 to 3 weeks; group 4, 3 to 4 weeks.
A retrospective analysis was performed to explore the
relationship between permanent and transient neurologic
deficits occurring after CEA and potential influential vari-
ables related to patient demographic data, extent of disease,
and diagnostic parameters. Dichotomized outcome vari-
ables determined at follow-up included presence or absence
of a permanent neurologic deficit, or presence or absence of
either a temporary or permanent neurologic deficit. Vari-
ables considered potentially associated with these outcomes
were diabetes, smoking history, coronary artery disease,
hypertension, stroke in evolution, and CT or MRI classifi-
cation variables before surgery. CT or MRI variables con-
sidered included presence of a detectable lesion, lesion size
in centimeters, and lesion location (NASCET).8,14 Binary
logistic regression was used to individually assess the asso-
ciation of these potential predictor variables with both
criteria of outcome success. Only univariate analysis was
performed; the number of adverse events was too small to
justify multivariate analysis. The low incidence of neuro-
logic deficit in these patients also has an effect in that type II
error is difficult to avoid, so negative findings with regard to
potentially influential factors should be treated with cau-
tion.
In addition, subanalysis of the differences between
groups with respect to demographic criteria and preopera-
tive brain imaging study data, as well as operative parame-
ters such as type of anesthesia, shunt use, and type of
endarterectomy, was performed. Beginning in 1999, pre-
operative and postoperative National Institutes of Health
Stroke Scale scores (NIHSSS) were determined. The po-
tential influence of these variables on development of post-
operative neurologic deficit was also evaluated. Differences
between groups in continuous variables such as patient age,
size of infarct, and NIHSSS were examined with analysis of
variance (ANOVA). Comparisons between groups in cate-
gorical variables were assessed with the 2 test or Fisher
exact test, when appropriate. Analysis was performed with
MINITAB Statistical Software (Minitab, State College,
Pa).
RESULTS
Over 22 years, 5845 CEA procedures were performed.
The indications for operation were asymptomatic stenosis
(70%) in 3632 procedures (62%), transient ischemic at-
tack in 1104 procedures (19%), amaurosis fugax in 556
procedures (10%), and minor stroke in 553 procedures
(9%). Within this group, 238 CEA procedures were per-
formed in 228 patients within 1 month of ipsilateral hemi-
spheric stroke. Although 10 patients ultimately underwent
bilateral CEA, no neurologic deficits or deaths were re-
corded in this group, and subsequent analysis of risk is on a
per patient basis rather than a per procedure basis. The
study population included 138 men (60%) and 90 women
(40%), with mean age 69 years (range, 36-94 years). Peri-
operative risk factors included diabetes mellitus (n  57,
25%), cigarette smoking (n 78, 34%), hypertension (n
104, 65%), and coronary artery disease (n  62, 37%).
Twelve patients underwent CEA within 24 hours to treat
stroke in evolution. The odds ratio (OR) for neurologic
deficit after CEA did not achieve statistical significance for
any of these variables (Table I), although the number of
neurologic deficits was small.
Preoperative brain imaging studies were available for
review in 72% (164/228) of patients undergoing CEA
prior to acute stroke. Lesions found on preoperative CT
and MRI studies were classified according to the criteria
utilized in NASCET as previously mentioned. There were
57 (35%) cortical, 27 (16%) small internal borderzone
infarcts and 21 (13%) deep infarcts in the vascular territory
of perforating arteries. In addition there were 59 (36%)
preoperative brain imaging studies in which there was no
infarct visualized in spite of acute fixed neurologic deficits.
There was no statistically significant association found be-
tween NASCET lesion criteria or location of lesion and the
development of perioperative neurologic deficit (Table II).
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However, increasing lesion size on preoperative CT scan or
MRI increased the odds of permanent neurologic deficit by
1.7 (95% confidence interval [CI], 1.1-2.8) per centimeter
of diameter.
With respect to interval between onset of stroke and
performance of CEA, there were no differences in infarct
location (P  .89, 2; Table III) or size (P  .11,
ANOVA). Of 228 patients with acute stroke, CEA was
performed in 69 patients within 1 week (group 1), in 57
patients within 1 to 2 weeks (group 2), in 28 patients within
2 to 3 weeks (group 3), and in 74 patients within 3 to 4
weeks (group 4).
Table I. Association of demographic variables with neurologic deficit in 228 patients
Potential risk factors
Patients
with
data
Patients with
risk factor Permanent neurologic deficit
Permanent or temporary neurologic
deficit
n % n % OR CI P n % OR CI P
All patients 228 228 100 7 3.1 13 5.7
Diabetes mellitus 228 57 25 0 0 0 0
Smoking history 228 78 34 3 3.8 1.2 0.3, 5.5 .82 5 6.4 1 0.3, 3.1 .99
Coronary artery
disease
167 62 37 0 0 2 3.2 0.5 0.1, 2.4 .36
Hypertension 161 104 65 3 2.9 1.7 0.2, 16.5 .66 5 4.8 0.9 0.2, 4 .91
Age (OR per year of
age; mean  SD)
228 69.2  10.1 69.3  9.7 1 0.9, 1.1 .99 68.6  9.3 1 0.9, 1.1 .81
OR, Odds ratio; CI, 95% confidence interval.
Odds ratio not computed when there were fewer than three cases. No risk factors were found to have significant influence (although it should be noted that
because of small numbers this lack of association may be a type II error.
Table II. Association of preoperative risk factors with neurologic deficit in 228 patients
Patients
with
data
Patients
with risk
factor (%) Permanent neurologic deficit
Permanent or temporary neurologic
deficit
n % n % OR CI P n % OR CI P
All patients 228 228 100 7 3.1 13 5.7
Stroke in evolution 228 12 5 0 0 2 16.7 3.9 0.8, 20 .10
Location (NASCET
criteria)
Borderzone 164 27 16 0 0 1 3.7
Cortical 164 57 35 4 2.4 8.2 0.9, 75.4 .06 5 8.8 2 0.6, 7.3 .28
Deep 164 21 13 1 0.6 1.8 0.2, 17 .60 2 9.5 1.9 0.4, 9.4 .46
None 164 59 36 0 0 2 3.4 0.43 0.1, 2.1 .28
Size (OR per cm; mean
 SD)
163 1.17  1.42 2.7  1.76 1.7 1.1, 2.8 .03 1.95  1.7 1.4 1, 2 .09
Stenosis (OR per degree) 198 84.7  13.6 82.1  10.7 1 0.9, 1 .59 81.9  12.1 1 1, 1 .42
Pre-NIHSSS 34 5  3.1 6  0 1.1 0.7, 1.7 .64
Post-NIHSSS 34 4.6  3.2 11  7.1 1.8 0.9, 3.6 .11
OR, Odds ratio; CI, 95% confidence interval; NASCET, North American Symptomatic Carotid Endarterectomy Trial; NIHSSS, National Institutes of Health
Stroke Scale score.
Odds ratio not computed when there were fewer than three cases. Mean not computed when there were fewer than two cases. Only size was found to have
significant influence (although it should be noted that because of small numbers this lack of association may be a type II error).
Table III. Location of preoperative infarct
Interval between stroke
onset and CEA (wk)
Cortical
infarct
Borderzone
infarct
Deep
infarct
No
infarct
Infarct size (cm;
mean  SD)
Patients with
data
Patients with
no datan % n % n % n %
0-1 21 38 10 17 7 12 18 33 1.4  1.6 56 13
1-2 14 39 4 11 6 17 12 33 1.3  1.3 36 21
2-3 4 21 3 16 3 16 9 47 0.7  0.9 19 9
3-4 18 34 10 19 5 9 20 38 1.0  1.4 53 21
CEA, Carotid endarterectomy.
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Operative factors potentially associated with presence
of neurologic deficit are shown in Table IV, and distribu-
tion of operative parameters across time intervals are shown
in Table V. Only use of the eversion technique was found to
have significant influence on neurologic deficit, because
patients undergoing eversion endarterectomy had less post-
operative neurologic deficit compared with patients under-
going standard CEA (Table IV, last row). The number of
weeks between occurrence of stroke and surgery did not
influence risk (Table IV), inasmuch as there was no signif-
icant difference in neurologic outcome of operative proce-
dure regardless of how long after stroke the surgery was
performed. There was also no detected influence on neu-
rologic deficit according to type of anesthesia, or use of a
patch or shunt (Table IV).
Two hundred one procedures (88%) were performed
with regional block anesthesia, and the remaining 27 pro-
cedures were performed with the patient under general
anesthesia. Intraluminal shunts were placed in 15 awake
patients (7% of the total population of patients) selectively
because of neurologic deterioration. Shunts were placed
routinely in 11 patients who received block anesthesia and
in 11 patients under general anesthesia. Operative param-
eters separated according to interval between onset of
stroke and operation are shown in Table V. There were no
differences in CEA technique, type of anesthesia, or use of
selective or routine shunting between the four intervals.
There was a significant association of eversion CEA tech-
nique and interval group, with eversion CEA more likely to
be performed early after stroke (Table V).
Operative mortality in the entire cohort was 1.3% (3 of
228 patients). Cause of death was cardiac-related in one
patient, who also had a postoperative permanent neuro-
logic deficit (Table VI), and in the other two patients was
related to postoperative permanent neurologic deficits.
Nonfatal permanent neurologic deficits occurred in an
additional four patients, for a stroke rate of 3.1% (7 of 228
patients). Five of these seven patients had associated post-
Table IV. Association of operative factors with neurologic deficit in 228 patients
Operative factors
Patients
with
data
Patients
with risk
factor Permanent neurological deficit Permanent or temporary neuro. deficit
n % n % OR CI P n % OR CI P
All patients 228 228 100 7 3.1 13 5.7
Eversion
technique
228 156 68 2 0.9 0.2 0, 1 .05 4 2.6 0.2 0.1, 0.7 .01
Use of shunt 213 22 10 1 0.5 0.9 0.1, 7.5.90 3 13.6 1.6 0.4, 6.2 .48
General anesthesia
(relative to
local)
222 25 11 0 0 0 0
Emergency 225 34 15 0 0 2 5.9 1.1 0.2, 5.1 .92
Use of patch 228 3 1 0 0 1 33.3 6.2 0.6, 63.8 .13
Weeks between
stroke and
surgery (OR per
week; mean 
SD)
228 2.47  1.23 2.4  1.3 1 0.5, 1.8.92 2.5  1.2 1 0.6, 1.6 .97
Odds ratio not computed when fewer than three cases. Mean not computed when fewer than two cases. Only eversion technique was found to have significant
influence (although it should be noted that because of small numbers, lack of association may be a type II error).
Table V. Operative parameters
Total
Interval (wk)
P
0-1 1-2 2-3 3-4
n % n % n % n % n %
Procedures 228 69 57 28 74
Eversion CEA 156 68 56 81 41 72 20 71 39 53 .003Standard CEA 72 31 13 19 16 28 8 29 35 47
Anesthesia: block 201 88 60 87 49 86 23 82 69 93 .367Anesthesia: general 27 12 9 13 8 14 5 18 5 7
Elective shunt 22 9 10 14 6 11 2 7 4 5
.548Emergent shunt 15 7 5 7 5 9 1 4 4 5
No shunt 19 54 46 25 66 0
CEA, Carotid endarterectomy.
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operative CEA thrombosis, with extension of the preoper-
ative infarct on brain imaging studies. In all cases, CEA
thrombosis was associated with development of a perma-
nent neurologic deficit. All five patients were returned to
the operating room, and emergent reconstruction proce-
dures included carotid artery bypass in four patients and
thrombectomy in one patient. Of the remaining two pa-
tients, one had hemorrhagic conversion of the preoperative
infarct and the other had a new ipsilateral cerebral infarct
most likely related to embolization during CEA.
Transient deficits resolving within 24 hours postoper-
atively occurred in 2.5% of all procedures (6 of 238). There
were no new infarcts or exacerbation of previous infarcts in
these patients. In addition, there were no postoperative
neurologic deficits in patients with stroke in evolution
undergoing CEA within 24 hours. Fatal and nonfatal com-
plications according to interval are shown in Table VI.
There was no significant difference between incidence of
postoperative neurologic deficit between intervals. Mean
length of stay was 7 days in groups 1 and 2, 9 days in group
3, and 8 days in group 4.
NIHSSS, compiled for 34 patients in the series, are
shown in Table VII. Patients undergoing CEA within 1
week of stroke had significantly greater scores both preop-
eratively and postoperatively compared with patients who
underwent CEA at any other interval (P .05). There were
no significant differences between distribution and location
of infarcts and NIHSSS before and after CEA. There was,
however, a significant relationship between preoperative
size of infarct and NIHSSS, determined with linear regres-
Table VI. Fatal and nonfatal complications
Time between stroke onset and time of surgery (wk)
0-1 1-2 2-3 3-4 Total
n % n % n % n % n %
Number of procedures 72 59 29 78 238
Mortality 0 2 3.4 1 3.4 0 3 1.3
Cardiac 0 1* 0 0 1 0.4
Permanent neurologic
deficit
0 1 1 0 2 0.8
Morbidity
Permanent neurologic
deficit
2 2.8 0 0 2 2.6 4 1.7
Transient neurologic
deficit
3 4.2 0 0 3 3.8 6 2.5
Occlusion 1 1.4 0 0 2 2.6 3 1.3
Wound hematoma 1 1.4 2 3.4 1 3.4 0 4 1.6
Cardiac 0 1 1.7 0 1 1.3 2 0.8
Nerve injury 0 0 0 1 1.3 1 0.4
Seizure 0 0 0 1 1.3 1 0.4
Total permanent neurologic
deficit (fatal and nonfatal)
2 2.8 2 3.4 1 3.4 2 2.6 7 2.9
*Also had permanent neurologic deficit.
Table VII. NIH stroke scale score (mean  SD)
Interval between stroke onset and surgery (wk)
0-1 1-2 2-3 3-4
Number of patients 21 9 3 1
NIHSSS
Preoperative 6.38  2.8* 3.67  1.7 0 1
Postoperative 5.9  3.2* 3.44  1.67 0 3
Depth and location of infarct
Cortical Borderzone Deep None
Number of patients 19 8 2 3
NIHSSS
Preoperative 5.4  3.2 5.0  3.0 4.0  1.4 4.3  3.8
Postoperative 5.3  3.5 3.6  2.0 4.0  1.4 4.3  3.8
NIHSSS, National Institutes of Health Stroke Scale score.
*P  .05.
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sion: NIHSSS  3.2  0.85  size of preoperative infarct
in centimeters (P  .01). The coefficient of determination
(r2) was 0.2.
DISCUSSION
The rationale for performing CEA after acute stroke is
to preserve neurologic function and prevent stroke exacer-
bation. Although this was the goal of surgeons performing
early CEAs in the late 1950s, the results of surgery after
acute stroke were attended by an unacceptably high rate of
neurologic complications.5,6,15 In patients with completed
stroke treated by Rob,5 operative mortality was 21%, with
improvement in only 47% of patients at hospital discharge.
Similar dismal results were reported by the Joint Study of
Extracranial Arterial Occlusive Disease3 and by Wylie et al.6
Most of the patients in these series underwent treatment of
acute carotid artery thrombosis in the setting of profound
preoperative neurologic deficits. Kusunoki et al16 per-
formed CEA in 40 patients with stroke after carotid throm-
bosis, with a 15% mortality rate and 17.5% stroke rate.
Although these results were not substantially better than in
previous studies, these authors were able to identify char-
acteristics of neurologic status that were associated with
poor outcome, and suggested that improved results might
be obtained in patients at reasonable medical risk with mild,
stable deficits.17
The emphasis of most recent reports dealing with the
time of CEA after acute stroke has been on defining a
population of patients who might benefit from surgery
within 4 to 6 weeks after stroke onset. Gasecki et al8
showed that CEA could be performed within 1 month after
nondisabling stroke, with mortality and morbidity compa-
rable to that after delayed endarterectomy. Results of the
present study show that in patients in whom neurologic
symptoms have plateaued after acute stroke, there is no
difference in incidence of postoperative neurologic deficit
after CEA performed at 1 to 4 weeks after stroke onset. In
the present study only 12 CEA procedures were performed
to treat stroke in evolution, whereas patients with profound
neurologic deficit and obtundation did not undergo CEA.
Although 315 patients underwent CEA more than 4 weeks
after stroke onset, and are not included in this survey, most
of these CEA procedures were performed early in our
experience. Stroke-related mortality in these patients was
no different from that in other patients with symptoms(9 of
315, 2.8%; P  .9, 2 test). We do not have complete data
for those patients who had strokes or worsening symptoms
during the intervening period between initial stroke and
CEA. Thus it is impossible to make a valid comparison
between the study group and patients in whom CEA was
performed more than 4 weeks after stroke.
Selection of an appropriate patient population would
seem to be important to obtaining a good result. Dosick et
al17 showed the safety of CEA within 2 weeks of stroke in
patients with no infarct on preoperative CT scans. In an
earlier report from Ricotta et al,18 patients with and with-
out CT evidence of infarction had vastly different outcomes
after CEA. Patients with an infarct had a 40% incidence of
stroke, whereas those with no infarct had a 6% stroke rate.
However, there was a heterogeneous group of patients in
this study with transient ischemia, fluctuating deficit, and
completed stroke; therefore it is difficult to determine
which patients with completed stroke had postoperative
neurologic decline. In a previous study of patients under-
going CEA within 6 months of stroke, we found no corre-
lation between time of surgery, extent of preoperative
infarct, and subsequent development of postoperative neu-
rologic dysfunction.19 In the present study, although size
of infarct affected risk for neurologic deficit, we found that
outcome of CEA performed at any time within 1 month of
stroke was comparable in patients with similar infarct size
and location at presentation.
Although depth and location of preoperative infarct did
not correlate with postoperative neurologic deficit, size of
infarct did. Risk for permanent neurologic deficit after CEA
increased by a factor of 1.73 with each 1-cm increase in
preoperative diameter of infarct. This finding differs from
most previous reports in which there was no correlation
with presence of infarction preoperatively and subsequent
risk for stroke.8,20,21 However, none of the previous re-
ports specifically compared risk for stroke with initial infarct
size.
Results of the present study suggest that patients with
larger infarcts may be at increased risk for postoperative
permanent neurologic deficits. It remains unclear whether
waiting longer than 4 weeks will reduce this risk; the
present study examined surgical treatment of patients
within 1 month of stroke. We have not delayed surgery in
these patients once neurologic status has plateaued or
evaluated an algorithm for delaying CEA on the basis of
size of preoperative infarct; therefore a randomized pro-
spective study will be necessary.
During the last 7 years of the study, there was also a
shift in type of CEA technique, from standard longitudinal
to eversion endarterectomy starting in the early to mid-
1990s. In parallel with the increase in use of the eversion
technique, there has been a significant increase in use of
routinely placed intraluminal shunts during CEA (P .05).
There were fewer postoperative neurologic deficits, either
permanent or temporary, with the eversion technique com-
pared with standard endarterectomy: 2.5% (4 of 158) and
11.2% (9 of 80), respectively (P  .01). In addition, there
were also significantly fewer permanent neurologic deficits
after eversion versus standard endarterectomy: 1.3% (2 of
158) and 6.2% (5 of 80), respectively (P .05). Within the
group of patients with post-CEA thrombosis, incidence of
thrombosis was greater after standard endarterectomy (4 of
80) compared with eversion endarterectomy (1 of 158) (P
 .05). In the present study, postoperative neurologic
deficits in five of seven patients were secondary to throm-
bosis of the endarterectomy site, and may be directly related
to technical errors. Ballotta et al20 and Riles et al22 reiter-
ated that the predominant cause of perioperative stroke is
technical and can be avoided by improving the details of the
procedure.
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Also in the latter part of the present study, we inserted
intraluminal shunts in more routinely, regardless of
whether the procedure was performed with the patient
under awake anesthesia with regional block or under gen-
eral anesthesia. It is therefore difficult to advocate for or
against shunt placement. The predominant use of intralu-
minal shunts during CEA by our group was not a reaction
to increased postoperative neurologic deficits with selective
shunting, but a concerted effort to minimize cerebral isch-
emia, extension of infarct, and reperfusion injury during
CEA. This change in the paradigm of treatment of acute
stroke was instituted by all vascular surgeons in our group.
In other studies, Piotrowski et al9 inserted shunts either
prophylactically or after low stump pressure in more than
85% of patients in whom CEA was performed within 6
weeks of stroke. Rosenthal et al23 demonstrated the unre-
liability of stump pressure measurement and electroen-
cephalographic monitoring in patients undergoing early
CEA after acute stroke. Routine shunting by that group
reduced the incidence of postoperative stroke from 38% to
0%. Although increased use of routine shunting in the latter
part of our study was not significantly associated with
substantially fewer postoperative neurologic deficits, the
incidence of neurologic deficit is so small that type II error
cannot be ruled out.
Toward the latter part of our study we performed CEA
in patients with larger preoperative cerebral infarcts. More
of these procedures within the last 2 years of the study were
performed less than 1 week from onset of acute stroke. The
delay between performance of CEA and onset of stroke was
determined primarily by time to referral to the vascular
surgeon. Appropriate stroke severity designation and risk
stratification has enabled us to treat many of these patients
with increasing radiologic and clinical severity, as assessed
by CT and MRI studies and NIHSSS, at earlier intervals.
Size of preoperative infarct also correlates with stroke score,
making this an effective tool to enable stratification of
perioperative risk with surgical and or radiologic interven-
tion. Although there was a trend toward improvement in
postoperative NIHSSS, it was not statistically significant.
In conclusion, CEA may be performed as early as 1
week after acute stroke, with acceptable results in patients
with mild to moderate preoperative neurologic deficits.
Use of the eversion endarterectomy technique and routine
shunting may contribute to improved patient outcome.
Risk for permanent postoperative neurologic deficit may be
predicted on the basis of infarct size on preoperative imag-
ing studies.
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